Healthcare & Life Sciences
XXII
United Statesportugal.gov.pt
XXII is a Healthcare & Life Sciences startup based in the United States, most recent round Series A, 2 tracked investors.
Activeseries-a
series-a
Stage
2
Investors
About XXII
XXII is a company headquartered in the United States. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
XXII, also known as 22nd Century Group, is a plant biotechnology company focused on tobacco harm reduction and cannabis research. They develop technologies to reduce nicotine in tobacco and modify cannabinoid profiles in cannabis.
Explore XXII's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.